EGFR and head and neck squamous cell carcinoma: It was reported that Aurora kinases were potential targets to overcome EGFR inhibitor resistance in HNSCC, indicating that Aurora kinase A (AURKA) blockade might be a promising approach (Kim and Bandyopadhyay, 2021).